Envestnet Asset Management Inc. Trims Stock Holdings in MetLife, Inc. (NYSE:MET)

Envestnet Asset Management Inc. lowered its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 1.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,901,403 shares of the financial services provider's stock after selling 45,460 shares during the quarter. Envestnet Asset Management Inc. owned 0.42% of MetLife worth $237,567,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Retirement Wealth Solutions LLC bought a new stake in shares of MetLife during the fourth quarter valued at approximately $32,000. Sierra Ocean LLC bought a new stake in MetLife during the 4th quarter valued at $32,000. Graney & King LLC bought a new stake in MetLife during the 4th quarter valued at $34,000. Values First Advisors Inc. purchased a new stake in shares of MetLife in the 4th quarter worth $36,000. Finally, Golden State Wealth Management LLC bought a new position in shares of MetLife during the 4th quarter worth $44,000. Institutional investors own 94.99% of the company's stock.

MetLife Stock Up 0.2 %

MET stock traded up $0.14 on Friday, hitting $71.25. 3,904,651 shares of the company's stock were exchanged, compared to its average volume of 3,401,496. The firm has a 50 day moving average price of $80.32 and a two-hundred day moving average price of $82.46. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $89.05. The stock has a market cap of $48.54 billion, a P/E ratio of 11.94, a price-to-earnings-growth ratio of 0.65 and a beta of 0.89. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16.

MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, equities research analysts expect that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts recently weighed in on the company. JPMorgan Chase & Co. decreased their price objective on MetLife from $88.00 to $86.00 and set an "overweight" rating for the company in a report on Wednesday, April 2nd. Wells Fargo & Company reduced their price target on shares of MetLife from $97.00 to $91.00 and set an "overweight" rating for the company in a report on Thursday. Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $98.00 to $95.00 and set an "outperform" rating on the stock in a research note on Wednesday. Piper Sandler lifted their price objective on shares of MetLife from $92.00 to $94.00 and gave the company an "overweight" rating in a report on Wednesday, April 2nd. Finally, StockNews.com lowered MetLife from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $92.46.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.